Uttarakhand Licensing Authority Suspends Licenses of 14 Patanjali Products
The Uttarakhand Licensing Authority has suspended the licenses of 14 Patanjali products with immediate effect, as per an affidavit filed in the Supreme Court. This action stems from a case involving misleading advertisements by Patanjali's Divya Pharmacy.
Products Affected by Suspension
The banned products include:
Drishti Eye dropn Swasari Goldn Swasari Vatin Bronchomn Swasari Pravahin Swasari Avalehn Mukta Vati Extra Powern Lipidomn Bp Gritn Madhugritn Madhunashini Vati Extra Powern Livamrit Advancen Livogritn Eyegrit Gold
Supreme Court Hearing
The Supreme Court will hear the matter related to the apology issued by Yoga guru Ramdev and Acharya Balkrishna on April 30. Both individuals are expected to appear in court on Tuesday.
Previous Court Action
During an earlier hearing on April 23, the Supreme Court criticized Patanjali for failing to display its apology prominently in newspapers. The court questioned the size of the apology relative to the full-page advertisements typically used by Patanjali to promote its products.
Following the court's order, Patanjali published a larger apology in newspapers. Prior to this, Ramdev and Balkrishna had submitted an unconditional and unqualified apology to the court regarding advertisements that made exaggerated claims about the effectiveness of products like Coronil during the pandemic.
Background of Case
In November 2023, the Indian Medical Association (IMA) filed a plea in the Supreme Court against Ramdev for criticizing modern medicine. The court subsequently directed Patanjali to cease advertising products that claimed to treat ailments prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Published: April 29, 2024
